82 filings
6-K
MDXH
MDxHealth SA
1 May 24
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
4:03pm
6-K
MDXH
MDxHealth SA
1 May 24
Unaudited Condensed Consolidated Statement of Profit or Loss
8:54am
424B5
MDXH
MDxHealth SA
30 Apr 24
Prospectus supplement for primary offering
5:20pm
20-F
2023 FY
MDXH
MDxHealth SA
Annual report (foreign)
30 Apr 24
4:02pm
6-K
MDXH
MDxHealth SA
12 Mar 24
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
5:01pm
6-K
b0bc5n7 qlzi4
6 Mar 24
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
5:04pm
6-K
yx6zb rv2j5px7
16 Feb 24
Mdxhealth Announces Resignation of Board Member
4:05pm
6-K
apum35
8 Jan 24
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues
4:39pm
6-K
ffepskh8dvzh5x2nb
19 Dec 23
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq
4:25pm
6-K
mcb 74zbis0
27 Nov 23
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq
4:01pm
8-A12B/A
ztum86t 8q39zk
24 Nov 23
Registration of securities on exchange (amended)
1:25pm
25-NSE
xt8b ru74q
24 Nov 23
Exchange delisting
1:24pm
6-K
69iddoj6uxd
15 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
1uyjqahae03khqa5e6p
13 Nov 23
MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights
5:06pm
6-K
s33jpix6 z8398m20ux6
8 Nov 23
Report of Foreign Private Issuer
4:23pm
6-K
r07bxq
8 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
bdc9rpauss5
6 Nov 23
Report of Foreign Private Issuer
8:00am
6-K
f33811q2m 4u46ev
23 Oct 23
Report of Foreign Private Issuer
5:09pm
6-K
yy77pw
11 Oct 23
Report of Foreign Private Issuer
4:50pm
6-K
baahga6a
10 Oct 23
MDxHealth Reports Preliminary Q3-2023 Revenues
6:12am